HEAL: HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart

Project: Research

Status	Finished
Effective start/end date	1/09/22 → 1/03/26

Deep immune-phenotyping of HLA-homozygous iPS-cardiomyocytes by spectral flow cytometry
Maeding, N. (First author), Suresh Kundully, D., Steinhuber, A. (Co-author), Kriedemann, N., Hernandez-Bautista, C. A., Martins, S., Hochmann, S. (Co-author), Wolf, M. (Co-author), Mayr, W., Jungbauer, C. (Co-author), Diecke, S., Tonn, T., Greber, B., Zweigerdt, R. & Strunk, D. (Last author), 4 Feb 2026, In: FRONTIERS IN IMMUNOLOGY. 17, 17, 13 p., 1736994.
Research output: Contribution to journal › Original Article › peer-review

Open Access
Advances in Extracellular Vesicle Research Over The Past Decade: Source And Isolation Method Are Connected with Cargo And Function
Poupardin, R. (First author), Wolf, M. (Co-author), Maeding, N. (Co-author), Paniushkina, L. (Co-author), Geissler, S., Bergese, P., Witwer, K. W., Schallmoser, K. (Co-author), Fuhrmann, G. & Strunk, D. (Last author), Jul 2024, In: ADVANCED HEALTHCARE MATERIALS. 13, 19, p. e2303941 14 p.
Research output: Contribution to journal › Review article › peer-review

Open Access

Deep Immunophenotyping of iPS-Cardiomyocytes
Strunk, D. (Keynote speaker)
16 Oct 2025
Activity: Talk or presentation › Invited talk
EV or not EV – das ist hier die Frage
Strunk, D. (Keynote speaker)
26 Sept 2025
Activity: Talk or presentation › Oral presentation
Next Generation Cell-based Therapies Part I+II
Strunk, D. (Keynote speaker)
6 Jun 2025
Activity: Talk or presentation › Invited talk

Project Details